|
Saddle River, NJ— (January 30, 2005) PDI, Inc. (NASDAQ: PDII) a diversified sales and marketing services provider to the biopharmaceutical industry, today announced that its President, Steve Budd, will be the keynote speaker at Strategic Research Institute's Pharmaceutical Marketing Summit Conference Series (PMS), being held April 4-5, at the Hyatt Regency, New Brunswick, NJ
In addition to his keynote address, Budd will also participate in panel presentations for the Pharma Marketing for Emerging and Early-Stage Companies and Sales Force Productivity conferences being held as part of PMS. Kathy Marsico, Executive Director, Human Resources, PDI and Susanne Reilly, Executive Director, Talent Management, PDI join Budd as panel participants during the Pharma Sales Force Productivity conference segment.
Specifically, the PDI Team will present
-
Steve Budd
Keynote Address, "Variable Sales Force Structures",
April 4, 12:45 - 1:30 PM.
In his address, Budd will discuss how the variable sales force structure model provides the industry with the ability to better respond to portfolio changes resulting from product-life cycles, brand acquisitions and other market pressures.
Panelist, "Developing and Optimizing Co-Promotion and Co-Marketing to Gain a Competitive Advantage," a panel presentation in Pharma Marketing for Emerging and Early-Stage Companies, April 4, 3:30-4:30 PM Panelists will explore how to identify the right partners and sales force structure to meet goals, as well as review strategic marketing issues and legal arrangements.
Panelist, "Segmentation and Targeting Strategies to Maximize ROI," a panel presentation in Pharma Sales Force Productivity,
April 5, 8:00 - 9:00 AM.
This interactive panel will discuss segmentation and target strategies to maximize ROI and increase sales growth.
-
Kathy Marsico
Panelist, "Beyond the Numbers: Developing a World Class Sales Force," a panel presentation in Pharma Sales Force Productivity,
April 4, 4:30 - 5:30 PM.
Kathy will join six other panelists in a lively discussion of the steps necessary to achieve a world class sales force, including strategy within the organization, aligning sales training with field realities and designing and implementing an effective training program that meets sales objectives.
-
Susanne Reilly
Panelist - "On-Going Development of Your Sales Force for Continued Improvement", a panel presentation in Pharma Sales Force Productivity, April 5, 11:00 AM - 12:00 PM.
This panel discussion will explore various strategies and opportunities needed to maximize sales force effectiveness and drive ROI. Reilly will draw upon her experience with developing and implementing PDI University as a development tool.
For more information contact:
Stephen P. Cotugno
Executive Vice President-Corporate Development
PDI, Inc.
201-574-8617
About PDI
PDI, Inc. (NASDAQ: PDII) is a diversified sales and marketing services provider to the biopharmaceutical industry. PDI's comprehensive set of outsourced sales and marketing solutions is designed to increase its clients' strategic flexibility and enhance their efficiency and profitability. Headquartered in Saddle River, NJ, PDI also has offices in Pennsylvania and Illinois.
PDI's sales and marketing services include our Performance Sales Teams™, which are dedicated teams for specific clients; and Select Access™, our targeted sales solution that leverages an existing infrastructure; marketing research and consulting; and medical education and communications. The company's experience extends across multiple therapeutic categories and includes office and hospital-based initiatives.
PDI's commitment is to deliver innovative solutions, unparalleled execution and superior results for its clients. Through strategic partnership and client-driven innovation, PDI maintains some of the longest standing sales and marketing relationships in the industry. Recognized as an industry pioneer, PDI remains committed to continued innovation.
For more information, visit the Company's website at www.pdi-inc.com.
Forward-Looking Statements
This press release contains forward-looking statements regarding future events and financial performance. These statements involve a number of risks and uncertainties and are based on numerous assumptions involving judgments with respect to future economic, competitive and market conditions and future business decisions, all of which are difficult or impossible to predict accurately and many of which are beyond PDI's control.
Some of the important factors that could cause actual results to differ materially from those indicated by the forward-looking statements are general economic conditions, changes in our operating expenses, adverse patent rulings, FDA, legal or accounting developments, competitive pressures, failure to meet performance benchmarks in significant contracts, changes in customer and market requirements and standards, the impact of
any stock repurchase programs, and the risk factors detailed from time to time in PDI's periodic filings with the Securities and Exchange Commission, including without limitation, PDI's Annual Report on Form 10-K for the year ended December 31, 2004, and PDI's periodic reports on Form 8-K filed with the Securities and Exchange Commission since January 1, 2005. The forward looking-statements in this press release are based upon
management's reasonable belief as of the date hereof. PDI undertakes no obligation to revise or update publicly any forward-looking statements for any reason.
|
